Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Adynxx Inc. (ADYX)

0.1804   -0.2 (-52.53%) 08-11 12:06
Open: 0.4 Pre. Close: 0.38
High: 0.4 Low: 0.1804
Volume: 1,193 Market Cap: 1M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.401 - 0.403 0.403 - 0.405
Low: 0.177 - 0.178 0.178 - 0.179
Close: 0.178 - 0.18 0.18 - 0.182

Technical analysis

as of: 2020-08-11 4:29:05 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.66     One year: 0.93
Support: Support1: 0.18    Support2: 0.15
Resistance: Resistance1: 0.56    Resistance2: 0.80
Pivot: 0.40
Moving Average: MA(5): 0.34     MA(20): 0.41
MA(100): 0.45     MA(250): 0.97
MACD: MACD(12,26): -0.05     Signal(9): -0.03
Stochastic oscillator: %K(14,3):     %D(3):
RSI: RSI(14): 24.81
52-week: High: 2.56  Low: 0.18  Change(%): -92.9
Average Vol(K): 3-Month: 125  10-Days: 32

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ADYX has closed below the lower band by 31.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 34.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 14 Nov 2019
Adynxx Reports Third Quarter 2019 Financial Results Other OTC:ADYX - GlobeNewswire

Tue, 22 Oct 2019
The 10 Top Penny Stocks to Watch This Week - Money Morning

Wed, 12 Jun 2019
Adynxx Stock to Move to OTC Market Following Receipt of Nasdaq Delisting Notice - GlobeNewswire

Fri, 10 May 2019
Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical - GlobeNewswire

Mon, 06 May 2019
Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors - GlobeNewswire

Mon, 22 Apr 2019
Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange: 
Sector: 
Industry: 
Shares Out. (M) 6
Shares Float (M)
% Held by Insiders 10.45
% Held by Institutions 71.81
Shares Short (K) 26
Shares Short P. Month (K) 18

Stock Financials

EPS -1.819
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -1.900
Profit Margin
Operating Margin
Return on Assets (ttm) -192.3
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.355
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio -0.10
PEG Ratio
Price to Book value -0.09
Price to Sales
Price to Cash Flow -0.17

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2019-05-28
Ex-Dividend Date 2019-05-05
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.